Feng W - Search Results

1

Clinical definition of secondary resistance to immunotherapy in non-small cell lung cancer.

Huang D, Lin G, Chu Q, Hu Y, Wang J, Wang Z, Yang F, Zhong W, Zhou C, Zhu B, Ai X, Cao B, Cao Y, Chen M, Chen X, Chu T, Duan J, Fan Y, Fang Y, Feng S, Feng W, Guo H, Han C, He Y, Hong S, Hu J, Huang M, Huang Y, Jiang D, Jiang K, Jiang R, Jin B, Jin S, Li J, Li M, Li Z, Li C, Lin J, Liu A, Liu SM, Liu Y, Liu Z, Liu Z, Liu Z, Liu Z, Liu Z, Lu Y, Lv T, Ma Z, Miao Q, Peng M, Pu X, Ren XB, Shan J, Shan J, Shen P, Shen B, Shi M, Song Y, Song Z, Su C, Sun J, Tian P, Wang J, Wang F, Wang H, Wang J, Wang Q, Wang W, Wang Y, Wu L, Wu F, Xia Y, Xie C, Xie C, Xin T, Xiong J, Xu H, Xu S, Xu Y, Xu B, Xu C, Yan X, Yang Z, Yao W, Yu Y, Feng Y, Yu Z, Yu Y, Yue D, Zhang H, Zhang H, Zhang L, Zhang L, Zhang Q, Zhang T, Zhang B, Zhao J, Zhao M, Zheng X, Zhong F, Zhou J, Zhou P, Zhu Z, Zou J, Zou Z. Huang D, et al. Among authors: feng y, feng s, feng w. Thorac Cancer. 2023 Dec;14(34):3421-3429. doi: 10.1111/1759-7714.15157. Epub 2023 Nov 14. Thorac Cancer. 2023. PMID: 37963454 Free PMC article.

2

[The application of needle video-assisted thoracoscopic biopsy in pathologic diagnosis and staging for advanced lung cancer].

Gu LJ, Wu YL, Feng WN, Weng YM, Cheng C, Zhong WZ, Huang SH. Gu LJ, et al. Zhonghua Jie He He Hu Xi Za Zhi. 2003 Jul;26(7):396-9. Zhonghua Jie He He Hu Xi Za Zhi. 2003. PMID: 12921642 Chinese.

3

[Treatment of non-small-cell lung cancer with paraplatin given by two different dosage calculation methods].

Gu LJ, Wu YL, Feng WN, Weng YM, Cheng C, Zhong WZ, Huang SH, Yang P. Gu LJ, et al. Zhonghua Zhong Liu Za Zhi. 2005 Jan;27(1):29-32. Zhonghua Zhong Liu Za Zhi. 2005. PMID: 15771794 Clinical Trial. Chinese.

4

[Predicting efficacy of neoadjuvant cheomotherapy on resectable stage IIIA non-small cell lung cancer by multi-gene expressions].

Cheng C, Wu YL, Gu LJ, Chen G, Weng YM, Feng WN, Zhong WZ. Cheng C, et al. Ai Zheng. 2005 Jul;24(7):846-9. Ai Zheng. 2005. PMID: 16004813 Clinical Trial. Chinese.

5

[The preliminary results of a phase II randomized clinical trial of high-dose toremifene chemosensitization in stage IIIB/IV non-small cell lung cancer].

Cheng H, Wu Y, Gu L, Feng W, Weng Y, Cheng C, Zhong W, Huang S. Cheng H, et al. Among authors: feng w. Zhongguo Fei Ai Za Zhi. 2003 Oct 20;6(5):335-8. doi: 10.3779/j.issn.1009-3419.2003.05.03. Zhongguo Fei Ai Za Zhi. 2003. PMID: 21306673 Free article. Chinese.

6

Randomized, Multicenter Study of Gefitinib Dose-escalation in Advanced Non-small-cell Lung Cancer Patients Achieved Stable Disease after One-month Gefitinib Treatment.

Xue C, Hong S, Li N, Feng W, Jia J, Peng J, Lin D, Cao X, Wang S, Zhang W, Zhang H, Dong W, Zhang L. Xue C, et al. Among authors: feng w. Sci Rep. 2015 Jul 28;5:10648. doi: 10.1038/srep10648. Sci Rep. 2015. PMID: 26216071 Free PMC article. Clinical Trial.

7

Toward an Expert Level of Lung Cancer Detection and Classification Using a Deep Convolutional Neural Network.

Zhang C, Sun X, Dang K, Li K, Guo XW, Chang J, Yu ZQ, Huang FY, Wu YS, Liang Z, Liu ZY, Zhang XG, Gao XL, Huang SH, Qin J, Feng WN, Zhou T, Zhang YB, Fang WJ, Zhao MF, Yang XN, Zhou Q, Wu YL, Zhong WZ. Zhang C, et al. Oncologist. 2019 Sep;24(9):1159-1165. doi: 10.1634/theoncologist.2018-0908. Epub 2019 Apr 17. Oncologist. 2019. PMID: 30996009 Free PMC article.

8

Efficacy, safety, and biomarker analysis of ensartinib in crizotinib-resistant, ALK-positive non-small-cell lung cancer: a multicentre, phase 2 trial.

Yang Y, Zhou J, Zhou J, Feng J, Zhuang W, Chen J, Zhao J, Zhong W, Zhao Y, Zhang Y, Song Y, Hu Y, Yu Z, Gong Y, Chen Y, Ye F, Zhang S, Cao L, Fan Y, Wu G, Guo Y, Zhou C, Ma K, Fang J, Feng W, Liu Y, Zheng Z, Li G, Wu N, Song W, Liu X, Zhao S, Ding L, Mao L, Selvaggi G, Yuan X, Fu Y, Wang T, Xiao S, Zhang L. Yang Y, et al. Among authors: feng j, feng w. Lancet Respir Med. 2020 Jan;8(1):45-53. doi: 10.1016/S2213-2600(19)30252-8. Epub 2019 Oct 15. Lancet Respir Med. 2020. PMID: 31628085 Clinical Trial.

9

A multicenter analysis of genomic profiles and PD-L1 expression of primary lymphoepithelioma-like carcinoma of the lung.

Xie Z, Liu L, Lin X, Xie X, Gu Y, Liu M, Zhang J, Ouyang M, Lizaso A, Zhang H, Feng W, Li B, Han-Zhang H, Chen S, Li S, Zhong N, Liu H, Zhou C, Qin Y. Xie Z, et al. Among authors: feng w. Mod Pathol. 2020 Apr;33(4):626-638. doi: 10.1038/s41379-019-0391-9. Epub 2019 Oct 28. Mod Pathol. 2020. PMID: 31659278 Free PMC article.

10

Prevalence and Clinical Impact of Concomitant Mutations in Anaplastic Lymphoma Kinase Rearrangement Advanced Non-small-Cell Lung Cancer (Guangdong Association of Thoracic Oncology Study 1055).

Li M, Hou X, Zhou C, Feng W, Jiang G, Long H, Yang S, Chen J, Wang N, Wang K, Chen L. Li M, et al. Among authors: feng w. Front Oncol. 2020 Aug 21;10:1216. doi: 10.3389/fonc.2020.01216. eCollection 2020. Front Oncol. 2020. PMID: 32974126 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6,461 results

Search Page